Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs Sionna Therapeutics, Inc. (SION)

Innate Pharma S.A. Sponsored ADR and Sionna Therapeutics, Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and Sionna Therapeutics, Inc. are of similar size ($160.9M and $148.3M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −99.7%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 10 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and Sionna Therapeutics, Inc. on 4.

Valuation

Metric IPHA SION Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.56 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.57 0.66
EV/Sales 0.12 n/m 9.02
Earnings yield (81.01%) (66.46%) (32.88%)
Free cash flow yield 0.00% (51.52%) (23.13%)

Profitability

Metric IPHA SION Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (99.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (32.34%) (51.96%)
Return on assets 0.00% (30.66%) (46.06%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric IPHA SION Biotechnology median
Revenue growth (TTM) (4.17%) — 6.76%
EPS growth (last fiscal year) 6.06% 88.24% 29.88%
Revenue growth, 5-year CAGR (33.86%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IPHA SION Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 20.05 4.97
Net debt to EBITDA 0.22 2.58 1.01

Dividend

Metric IPHA SION Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPHA SION Biotechnology median
Market cap 160.85m 148.30m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack